Analysis of liquid crystalline nanoparticles by small angle X-ray diffraction: Evaluation of drug and pharmaceutical additives influence on the internal structure

Journal of Pharmaceutical Sciences

Volumn 100, Issue 7, 2011, Pages 2849-2857

  Rossetti, Fábia Cristina ^a   Fantini, Márcia C A ^a   Carollo, Aline Regina H ^a   Tedesco, Antônio Cláudio ^a   Lopes Badra Bentley, Maria Vitória ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Drug delivery system; Formulation additives; Light scattering; Lipids; Liquid crystal; Nanodispersion; Nanoparticles; Skin; Solubility; X ray diffractometry

Indexed keywords

DRUG ADDITIVE; NANOPARTICLE; PHOTOSENSITIZING AGENT; POLYMER; PRESERVATIVE;

ANISOTROPY; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DISPERSION; DRUG ANALYSIS; DRUG DELIVERY SYSTEM; DRUG STABILITY; DRUG STRUCTURE; LIGHT SCATTERING; LIQUID CRYSTAL; MICROSCOPY; PHOTODYNAMIC THERAPY; X RAY CRYSTALLOGRAPHY;

EID: 79955593870     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22522     Document Type: Article

References (34)

1. Singh S. 2000. Phase transitions in liquid crystals. Phys Rep 324:107-269.
2. Larsson K, Fontell K, Krog N. 1980. Structural relationships between lamellar, cubic and hexagonal phases in monoglyceride-water systems. Possibility of cubic structure in biological systems. Chem Phys Lipids 27:321-328.
3. Larsson KJ. 1989. Cubic lipid-water phases: Structure and biomembranes aspects. J Phys Chem 93:7304-7314.
4. Qiu H, Caffrey M. 2000. The phase diagram of the monoolein/water system: Metastability and equilibrium aspects. Biomaterials 21:223-234.
5. Bornè J, Nylander T, Khan A. 2001. Phase behavior and aggregate formation for the aqueous monoolein system mixed with sodium oleate and oleic acid. Langmuir 17:7742-7751.
6. Nakano M, Teshigawara T, Sugita A, Leesajakul W, Taniguchi A, Kamo T, Matsuoka H, Handa T. 2002. Dispersions of liquid crystalline phases of the monoolein/oleic acid/pluronic F127 system. Langmuir 18:9283-9288.
7. Lopes LB, Ferreira DA, de Paula D, Garcia MTJ, Thomazini JA, Fantini MCA, Bentley MVLB. 2006. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: In vitro and in vivo skin penetration of cyclosporin A. Pharm Res 23:1332-1342.
8. Lopes LB, Speretta FFF, Bentley MVLB. 2007. Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems. Eur J Pharm Sci 32:209-215.
9. Boyd BJ, Whittaker DV, Khoo S, Davey G. 2006. Hexosomes formed from glycerate surfactants-Formulation as a colloidal carrier for irinotecan. Int J Pharm 318:154-162.
10. Mishraki T, Libster D, Aserin A, Garti N. 2010. Lysozyme entrapped within reverse hexagonal mesophases: Physical properties and structural behavior. Colloids Surf B Biointerfaces 1:47-56.
11. Libster D, Aserin A, Yariv D, Shoham G, Garti N. 2009. Soft matter dispersions with ordered inner structures, stabilized by ethoxylated phytosterols. Colloids Surf B Biointerfaces 74:202-215.
12. Landh T. 1994. Phase behavior in the system pine needle oil monoglycerides-poloxamer 407-water at 20.degree. J Phys Chem 98:8453-8467.
13. Imberg A, Evertsson H, Stilbs P, Kriechbaum M, Engstrom S. 2003. On the self-assembly of monoolein in mixtures of water and a polar aprotic solvent. J Phys Chem B 109:2311-2318.
14. Ferreira DA, Bentley MVB, Karlsson G, Edwards K. 2006. Cryo-TEM investigation of phase behaviour and aggregate structure in dilute dispersions of monoolein and oleic acid. Int J Pharm 310:203-212.
15. II liquid crystal-based delivery system for cyclosporin A: Physical characterization. J Colloid Interface Sci 308:514-524.
16. De Rosa FS, Bentley MVLB. 2000. Photodynamic therapy of skin cancers: Sensitizers, clinical studies and future directives. Pharm Res 17:1447-1455.
17. Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, Roelandts R, Wennberg AM, Morton CA. 2007. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus. J Am Acad Dermatol 56:125-143.
18. Brow SB, Brow EA, Walker I. 2004. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 5:497-508.
19. Miller JD, Baron ED, Scull H, Hsia A, Berlin JC, McCormick T, Colussi V, Kenney ME, Cooper KD, Oleinick NL. 2007. Photodynamic therapy with the phthalocyanine photosensitizer Pc 4: The case experience with preclinical mechanistic and early clinical-translational studies. Toxicol Appl Pharmacol 224:290-299.
20. Castano AP, Demidova T, Hamblin MR. 2005. Mechanisms in photodynamic therapy: Party one-Photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 2:91-106.
21. Lara MG, Bentley MVLB, Collett JH. 2005. In vitro drug release mechanism and drug loading studies of cubic phase gels. Int J Pharm 293:241-250.
22. Esposito E, Eblovi N, Rasi S, Drechler M, Di Gregorio G, Menegatti E, Cortesi R. 2003. Lipid-based supramolecular systems for topical application: A preformulatory study. AAPS PharmSci 5:1-15.
23. Lopes LB, Lopes JCL, Oliveira DCR, Thomazini JA, Garcia MTJ, Fantini MCA, Collett JH, Bentley MVLB. 2006. Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: Characterization and study of in vitro and in vivo delivery. Eur J Pharm Biopharm 63:146-155.
24. Yaghmur A, Glatter O. 2009. Characterization and potential applications of nanostructured aqueous dispersions. Adv Colloid Interface Sci 147:333-342.
25. Gustafsson J, Ljusberg-Wahren H, Almgren M, Larsson K. 1997. Submicron particles of reversed lipid phases in water stabilized by a nonionic amphiphilic polymer. Langmuir 13:6964-6971.
26. Amar-Yuli I, Wachtel E, Shoshan EB, Danino D, Aserin A, Garti N. 2007. Hexosome and hexagonal phases mediated by hydration and polymeric stabilizer. Langmuir 23:3637-3645.
27. Caboi F, Amico GS, Pitzalis P, Monduzzi M, Nylander T, Larsson K. 2001. Addition of hydrophilic and lipophilic compounds of biological relevance to the monoolein:water system. I. Phase behavior. Chem Phys Lipids 109:47-62.
28. Amar-Yuli I, Aserin A, Garti N. 2008. Solubilization of nutraceuticals into reverse hexagonal mesophases. J Phys Chem B 112:10171-10180.
29. Amar-Yuli I, Garti N. 2005. Transitions induced by solubilized fat into reverse hexagonal mesophases. Colloids Surf B Biointerfaces 43:72-82.
30. Amar-Yuli I, Wachtel E, Shalev DE, Aserin A, Garti N. 2008. Low viscosity reversed hexagonal mesophases induced by hydrophilic additives. J Phys Chem B 112:3971-3982.
31. Koynova R, Brankov J, Tenchov B. 1997. Modulation of lipid phase behavior by kosmotropic and chaotropic solutes. Experiment and thermodynamic theory. Eur Biophys J 25:261-274.
32. Nunes SMT, Sguilla FS, Tedesco AC. 2004. Photophysical studies of zinc phthalocyanine and chloroaluminum phthalocyanine incorporated into liposomes in the presence of additives. Braz J Med Biol Res 37:273-284.
33. Scolaro LM, Castriciano M, Romeo A, Patanè S, Cefalì E, Allegrini M. 2002. Aggregation behavior of protoporphyrin IX in aqueous solutions: Clear evidence of vesicle formation. J Phys Chem B 106:2453-2459.
34. Whitlock JB, Bird GR, Cox MD, Panayotatos P. 1992. Hydration of chloroaluminum phthalocyanine. Thin Solid Films 215:84-87.